When Dr. Khwaja Abdul Hamied founded The Chemical, Industrial & Pharmaceutical Laboratories in 1935, it aimed at making medicines affordable for all, thereby making India self-reliant in healthcare. Now known as Cipla, what Dr. Hamied had begun has become a multinational company that is one among the largest manufacturers of generic pharmaceutical formulations.
Cipla provides medicines for a range of acute and chronic illness including communicable, non-communicable, common and rare diseases. They are categorized under 65 labels of different dosages. Cipla focuses primarily on developing medicines for respiratory disease, cardiovascular disorders, arthritis, diabetes, weight control and depression.
The development of antiretrovirals for the treatment of HIV is one of Cipla’s notable achievements. It is now one of the world’s leading manufacturers of antiretrovirals (ARV). They also supply these medicines at a comparatively lower cost.
Picture Credit : Google
